Quantcast

Latest Radiofrequency ablation Stories

2014-06-09 08:30:45

LONDON, June 9, 2014 /PRNewswire/ -- Reportbuyer.com has added a new market research report: U.S. Market for Cardiac Rhythm Managment, Electrophysiology and Ablationhttp://www.reportbuyer.com/pharma_healthcare/medical_devices/u_s_market_cardiac_rhythm_managment_electrophysiology_ablation.html In 2012, the U.S. market for cardiac rhythm management (CRM), electrophysiology and ablation devices market was valued at nearly $6.8 billion.The CRM, electrophysiology and ablation device...

2014-05-21 08:29:17

- On Track for Study Participation in Major HCC Markets Worldwide - LAWRENCEVILLE, N.J., May 21, 2014 /PRNewswire/ -- Celsion Corporation (NASDAQ: CLSN) today announced it has received regulatory clearance to initiate its Phase III OPTIMA Study at clinical trial sites in Taiwan, Hong Kong, South Korea and Canada. The OPTIMA Study is the Company's planned global pivotal, double-blind, placebo-controlled study evaluating ThermoDox®, its proprietary heat-activated liposomal...

2014-05-16 12:27:07

TIANJIN, China, May 16, 2014 /PRNewswire/ -- Recently, TEDA International Cardiovascular Hospital (hereinafter referred to as "TEDA") successfully performed the cryoballoon ablation surgery of atrial fibrillation (AF) on two AF patients. It is reported that extremely few hospitals in China can make such operation and it is also the first time in Tianjin. The 61-year-old Granny Zhang, a paroxysmal AF patient who lives in the Tanggu district of Tianjin, has received the surgery....

2014-05-16 08:26:24

Abstract Presents a Retrospective Analysis of the Company's 701 Patient HEAT Study and Compelling Data Showing Enhanced Efficacy When Radiofrequency Ablation is Combined with ThermoDox and When Heating Time of the RFA Procedure is Greater Than 45 Minutes LAWRENCEVILLE, N.J., May 16, 2014 /PRNewswire/ -- Celsion Corporation (NASDAQ: CLSN), an oncology drug development company, today announced that an abstract on its Phase III HEAT Study of ThermoDox, the Company's proprietary...

2014-04-28 16:30:48

LONDON, April 28, 2014 /PRNewswire/ -- Reportbuyer.com has added a new market research report: US Cardiac Surgery and Heart Valve Devices Markethttp://www.reportbuyer.com/pharma_healthcare/medical_devices/us_cardiac_surgery_heart_valve_devices_market.html The U.S. market for Cardiac Surgery and Heart Valve Device s will grow at a CAGR of 9.5% over theforecast period.The U.S. market for Cardiac Surgery and Heart Valve Device s is being sustained by the stability oftraditional...

2014-04-24 08:32:37

Latest Data Sweep from Large Subgroup of Patients Shows a Strong 50% Improvement in Overall Survival for ThermoDox® LAWRENCEVILLE, N.J., April 24, 2014 /PRNewswire/ -- Celsion Corporation (NASDAQ: CLSN) today announced that updated results from the 701 patient HEAT Study post-hoc analysis, as well as a review of the final study design of the Phase III OPTIMA Study, which both explore ThermoDox®, Celsion's proprietary heat-activated liposomal encapsulation of doxorubicin, in...

2014-04-18 16:22:54

- Led by New Enterprise Associates and Experienced Medical Device Industry Veterans, Financing Will Support Development of Next Generation TempaSure(TM) Radiometric Temperature-Sensing Radio-Frequency Ablation Catheter Capable of Accurate, Real-Time Volumetric Temperature Measurement During Irrigated Ablation MENLO PARK, Calif., April 18, 2014 /PRNewswire/ -- Advanced Cardiac Therapeutics, Inc. ("ACT"), a medical device company that is developing a novel, temperature-sensing,...

2014-04-14 12:33:30

Epidemiological, genetic and clinical data presented today at the International Liver CongressTM 2014 are collectively focused on different approaches designed to improve the diagnosis, staging and treatment of hepatocellular carcinoma (HCC). "Human hepatocellular carcinoma is one of the most prevalent cancers worldwide and the second most frequent cause of cancer-related death," said EASL's Scientific Committee Member Dr Helen Reeves Senior Lecturer & Honorary Consultant...

2014-04-11 08:25:08

Company Trademarks Technology As COOLIEF* Cooled Radiofrequency Treatment ROSWELL, Ga., April 11, 2014 /PRNewswire/ -- Kimberly-Clark Health Care today announced the launch of MyCoolief.com, a consumer website designed to provide patients with information about its COOLIEF* Cooled Radiofrequency Treatment, a minimally invasive and non-surgical outpatient procedure used by interventional pain physicians to target the nerves causing chronic back pain in long-term sufferers....

2014-04-10 08:30:03

Professor Riccardo Lencioni is giving an honorary lecture on April 24, 2014 which will highlight the latest findings and lessons learned from the HEAT Study and the design of the Phase III OPTIMA Study LAWRENCEVILLE, N.J., April 10, 2014 /PRNewswire/ -- Celsion Corporation (NASDAQ: CLSN) announced today that Professor Riccardo Lencioni, MD, FSIR, EBIR, Professor and Director of the Diagnostic Imaging and Intervention at the Pisa University School of Medicine in Italy, former ECIO President,...


Word of the Day
out-herod
  • In the phrase to out-herod Herod, to be more violent than Herod (as represented in the old mystery plays); hence, to exceed in any excess of evil.
Herod refers to 'Herod the Great,' a Roman client king and 'a madman who murdered his own family and a great many rabbis.' According to the OED, the term is 'chiefly with allusion to Shakespeare's use' in Hamlet.
Related